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SUMMARY 
2,5-Bis(1-aziridinyl)-l,4-benzoquinone (BABQ) is a compound from which 
several antitumour drugs are derived, such as Trenimone, Carboquone and 
Diaziquone (AZQ). The mechanism of DNA binding of BABQ was studied 
using 14C-labeled BABQ and is in agreement with reduction of the quinone 
moiety and protonation of the aziridine ring, followed by ring opening and 
alkylation. The one-electron reduced (semiquinone) form of BABQ alkylates 
DNA more efficiently than two-electron reduced or non reduced BABQ. Cov- 
alent binding to polynucleotides did not unambiguously reveal preference for 
binding to specific DNA bases. Attempts to elucidate further the molecular 
structure of DNA adducts by isolation of modified nucleosides from enzy- 
matic digests of reacted DNA failed because of instability of the DNA 
adducts. The mechanism of covalent binding to protein (bovine serum albu- 
min, BSA) appeared to be completely different from that of covalent binding 
to DNA. Binding of BABQ to BSA was not enhanced by reduction of the 
compound and was pH dependent in a way that is opposite to that of DNA 
alkylation. Glutathione inhibits binding of BABQ to BSA and forms adducts 
with BABQ in a similar pH dependence asthe protein binding. The aziridine 
group therefore does not seem to be involved in the alkylation of BSA. Incu- 
bation of intact E. coli cells, which endogenously reduce BABQ, resulted in 
binding to both DNA and RNA, but also appreciable protein binding was 
observed. 
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INTRODUCTION 
After the discovery of tumour growth inhibiting effects of sulfur- and 
nitrogen mustard compounds, alkylating agents containing aziridinyl groups 
have been developed. The combination of aziridinyl and a benzoquinone 
moiety by Domagk et al. [1] yielded 2,5-bis(1-aziridinyl)-l,4-benzoquinone 
(BABQ, Fig. 1), a compound with remarkable antineoplastic properties, but 
also dose-limiting toxicity [2]. Later, a series of BABQ derivatives was 
screened by Driscoll et al. [3] for activity against brain tumours. From this 
series, Diaziquone (AZQ) was one of the most promising compounds. This 
compound has been used in many clinical phase I and II trials and appears to 
be active against brain tumours in man [4,5] and several other tumours. The 
BABQ compounds are (bio)reductively activated rugs, a term introduced by 
Lin et al. [6], like other antitumour agents containing a quinone moiety, such 
as adriamycin and mitomycin C (for a review, see Powis [7]). Reduction of the 
benzoquinone moiety strongly enhances the alkylating activity of BABQ 
derivatives [8]. Bioreductively activated drugs are of potential use against 
solid tumours, which contain hypoxic parts due to poor vascularization; 
hypoxia is thought to favour the reduced state of a compound, by slowing 
reoxidation [9]. Moreover, due to the aziridine ring BABQ derivatives are 
acid-activated to alkylating species. This may increase tumour cell specific- 
ity, as in some tumour tissues, especially hypoxic tissues, the pH is lower 
than in normal tissues [10,11]. 
Previously, we investigated the effects of DNA damage by a series of 3,6- 
substituted BABQ derivatives in a bacterial differential DNA repair test and 
a bacteriophage DNA inactivation test [12]. Further, we reported on DNA 
cross-linking by these compounds [8]. The parent compound BABQ showed a 
high capacity to inactivate DNA as well as to form DNA cross-links. To 
study DNA alkylation by this compound in more details, we synthesized 14C- 
labeled BABQ. 
In the present study, the dependence of DNA binding upon pH and reduc- 
tion is investigated. We demonstrate that the one-electron reduced semiqui- 
none form is mainly responsible for DNA alkylation. Base-sequence 
preference is investigated by studying binding to several synthetic polynu- 
o 
o 
Fig. 1. Structure of 2,5-bis(1-aziridinyl)-l,4-benzoquinone (BABQ). 
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cleotides. Binding of BABQ to protein appears to proceed with a mechanism 
that is essentially different from that of DNA binding. To study covalent 
binding in intact cells, we measured bacterial DNA and protein binding in E. 
coli exposed to BABQ, which is activated by endogenous bacterial reductive 
enzymes. 
MATERIALS AND METHODS 
2,5-[:4C]Bis(1-aziridinyl)-l,4-benzoquinone was prepared from 2,3,5,6,-[14C]- 
1,4-benzoquinone (17 mCi/mmol, from Amersham) as described in the litera- 
ture [13] and diluted with unlabeled 2,5-bis(1-aziridinyl~l,4-benzoquinone to 
obtain a specific activity of 5.6 x 109 Bq • tool-:, determined by scintillation 
counting and spectrophotometry (the molar absorptivity at 324 nm was 
determined to be 1.75 × 104 M -1 • cm-1) .  The radiochemical purity was 
checked by TLC analysis on Silica plates (Merck alufoil Kieselgel 60F254), 
developed in chloroform/methanol (10:1), followed by autoradiography. No 
other products were detectable on the autoradiogram. A stock solution con- 
taining 2.25 mM BABQ in dimethylformamide was prepared and stored at 
4°C in the dark. Calf thymus DNA was from Sigma Chemical Company (St. 
Louis, MO). Poly(dA) poly(dT), poly(dA • dT), poly(dG) • poly(dC) and 
poly(dG • dC) were from Boehringer (Mannheim, F.R.G.). Identity and purity 
were confirmed by recording melting curves, [14]. Stock solutions of DNA 
and polynucleotides in water were 3.88 raM, calculated as phosphate and 
determined spectrophotometrically using extinction coefficients given by 
Wells et al. [14]. BSA, demineralized, was from Poviet Producten BV (Boxtel, 
The Netherlands). DNase I (EC 3.1.21.1.), nuclease P1 (EC 3.1.10.1) and alka- 
line phosphatase (EC 3.1.3.L) were from Boehringer Mannheim GmbH. E.. 
coli K12-343/753 ("wild type") and 343/765 (defective in recA and uvrB genes) 
were kindly provided by G.R. Mohn (R.I.V.M., Bilthoven, The Netherlands). 
For a full description of growing and maintenance of the strains, see Mohn 
et al. [15]. Ingredients for bacterial media were obtained from Difco Labora- 
tories (Detroit, MI). Glucose-phosphate buffer contained 2.8 g of glucose per 
100 ml in 60 mM phosphate buffer (pH 7.1). Doubly distilled water was used 
in all experiments. Methanol for HPLC was from Baker Chemicals. All other 
chemicals were analytical grade. 
Scintillation counting was performed on a Packard Minaxi-/3 Tri-Carb 4430 
Liquid Scintillation Counter, using Hydro-Luma scintillation cocktail (Lumac 
BV, Landgraaf, The Netherlands). Counting efficiency was determined by the 
internal channel ratio method. HPLC analyses were performed on a Spectra- 
Physics SP8400 HPLC system with a SP8440 UV-detector, using a Spheri- 
sorb $5-0DS2 column. UV-VIS spectra were recorded on a Perkin-Elmer 
Lambda-5 spectrophotometer. Fast atom bombardment (FAB) mass spectra 
were obtained with a VG-ZAB-2f mass spectrometer (VG-Analytical, Man- 
chester, U.K.), equipped with a Saddlefield ion gun (1 mA, 7 kV) using xenon 
gas. Electrochemical reduction was performed under nitrogen bubbling in a 
vessel kept at 25°C, using a Radiometer K401 saturated calomel electrode, a
platinum wire auxiliary electrode, a 2-ml mercury pool as cathode and a 
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Brooker El00 as potentiostat, at a potential 200 mV more negative than the 
halfwave potential of the compound. Nitrogen was made oxygen-free photo- 
reductively by passing the nitrogen through an illuminated solution contain- 
ing 0.1 M pyrophosphate, 0.1 M EDTA, 4 mM methyl viologen and 40 ~M 
proflavine, as described [16]. 
BABQ binding to DNA and polynucleotides 
A mixture containing 225 ~M [~4C]BABQ and 25 mM Tris-acetate buffer 
(pH 7.0) was electrochemically reduced. After reduction, 20 ~l of this solution 
was added to a mixture of 20 ~l DNA or polynucleotide stock solution and 4 
~1 Tris-acetate buffer of varying pH (1 M). After 90-min incubation at 37°C, 
DNA and DNA-adducts were separated from BABQ and its decomposition 
products by Sephadex G-50 spun column filtration [17]. The Sephadex eluate 
was mixed with scintillation cocktail and counted. Control experiments with- 
out BABQ reduction have also been performed. 
Time-dependence of BABQ binding to calf thymus DNA 
A mixture containing 225 ~M [14C]BABQ, 0.6 mg • m1-1 calf thymus DNA 
(2.0 mM as phosphate) and 5 mM Tris-acetate buffer (pH 5.0) was electro- 
chemically reduced under nitrogen at 25°C. During reduction, the cathode 
reduction current was registrated. At timed intervals, samples of 100 ~l 
were taken, filtrated over Sephadex G-50 columns by spun column filtration 
and assayed for amount of radiolabel. After 105 min, reduction was stopped, 
Tris-acetate buffer (pH 7.0) was added to a final concentration of 100 ~M and 
the mixture was incubated under air at three temperatures: 25°C, 37°C and 
45°C. At timed intervals, samples of 100 ~l were taken and treated as 
described above. Similar experiments were also performed with unreduced 
BABQ. 
To study binding exclusively by fully (two-electron) reduced BABQ, a mix- 
ture containing 450 ~M [14C]BABQ and 5 mM Tris-acetate buffer (pH 7.0) was 
electrochemically reduced under nitrogen at 25 °C. After completion of reduc- 
tion, an equal volume of a nitrogen-saturated solution containing 1.2 mg • 
m1-1 calf thymus DNA (3.9 mM as phosphate) in 200 mM Tris-acetate (pH 5.0) 
was added. Reduction was continued and at timed intervals, samples of 100 
~l were taken and treated as described earlier in this section. 
Analysis of BABQ-DNA adducts 
BABQ-DNA adducts were obtained by electrochemical reduction under 
nitrogen, of a mixture containing 0.5 mg • m1-1 calf thymus DNA and 2 mM 
BABQ in 50 mM phosphate buffer (pH 6.0) for 60 min at 25°C and subse- 
quent reoxidation under air for 120 min at 25°C. DNA containing BABQ 
adduct was separated from BABQ products by chromatography on a 20-ml 
Sephadex G-25 column and subsequent extractions with 1-butanol and di- 
ethyl ether. The yield of DNA adducts as judged from UV absorbance was 
approximately one adduct per 30 basepairs. DNA was enzymatically digested 
by incubating the solution with 100 units • m1-1 DNAse I and 10 ~g • ml -~ 
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nuclease P1 in 50 mM acetate buffer (pH 5.5) containing 0.6 mM ZnS0 4 and 
10 mM MgSO 4 for 3 h at 37°C [18]. DNA degradation was followed by mea- 
suring the increase of absorbance at 260 nm (A260). After 3-h incubation, the 
amount of DNase I and nuclease P1 was doubled and the digestion was con- 
tinued for another 60 rain. When no more increase in A260 was observed, the 
pH of the solution was raised to 8.0 by addition of a 1-M tris-solution. Alka- 
line phosphatase was added to a concentration of 2 units • m1-1 and the solu- 
tion was incubated at 37°C for 30 min. Undigested DNA was precipitated 
with ethanol and removed by centrifugation. The supernatant was concentra- 
ted in a Speedvac and submitted to HPLC analysis• Gradient elution was 8 
performed from 100% buffer (100 mM acetate, pH 3.3) to 100% methanol in 
60 rain, flow rate 1 ml • rain -1. Detection was at 343 nm, the UV maximum of 
the DNA-BABQ adduct and 275 nm. Main adduct peaks were quantitatively 
collected by repeated injections, lyophilized and after dissolution again sub- 
mitted to HPLC analysis, this time with gradient elution from 100o/o buffer 
(10 mM ammonium acetate, pH 7.2) to  100o/o methanol in 60 min, flow rate 
1 ml • min -1. UV spectra of the main adduct peaks were recorded. Products 
were again lyophilized and submitted to mass spectral analysis. 
Binding of BABQ to albumin 
A mixture containing 225 wM [14C]BABQ and 10 mM Tris-acetate buffer 
(pH 7.0) was electrochemically reduced. After reduction 100 ~l of this solu- 
tion was added to a mixture of 100 pl of bovine albumin stock solution (15 mg 
• m1-1) and 20 ~l of Tris-acetate buffer of varying pH (1 M). After 90 rain 
incubation at 37 °C, samples were treated as described under "BABQ binding 
to DNA and polynucleotides". Similar experiments have also been performed 
with unreduced BABQ. 
To study the influence of glutathione and cysteine on the protein binding, 
100 ~1 of the 225 ~M [~4C]BABQ solution was added to 20 ~1 Tris-acetate 
buffer (pH 8.0) (1 M) and 100 ~l of a mixture of 1.5 mg • m1-1 bovine albumin 
and 225 ~ glutathione (pH 8.0) or 225 ~M cysteine (pH 8.0). After 1 h incu- 
bation at 37°C, samples were treated as described under "BABQ binding to 
DNA and polynucleotides". 
To study the pH-dependence of binding of BABQ to glutathione, 100 ~l of 
the 225 ~M [14C]BABQ solution was added to a mixture of 20 ~l Tris-acetate 
buffer of varying pH (1 M) and 100 pl glutathione solution (225 pM, pH 
adjusted to corresponding value). After 2-h incubation at 37°C, the samples 
were analyzed by HPLC using 5 mM Tris-acetate buffer (pH 7.6) as eluent. 
Detection was at 340 rim. After this, the column was washed with methanol 
to elute BABQ and its decomposition products. The buffer-eluted fractions, 
containing glutathione-BABQ adducts (see Results and Discussion), were col- 
lected, adjusted to a volume of 10 ml and scanned spectrophotometrically. 
The amount of glutathione adduct present in the sample was assayed using 
the absorption at 340 nm. 
Binding of BABQ to bacterial macromolecules in situ 
Overnight cultures of E. coli strains (10 ml) were washed twice with 10 ml 
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of glucose-phosphate buffer (pH 7.0) and incubated in 10 ml of glucose-phos- 
phate buffer (pH 7.0) at 37°C under shaking. The t i ter of the E. coli suspen- 
sion was determined by plating. [14C]BABQ stock solution was added to a 
final concentration of 10 ~M. After 90-min incubation, 5-ml samples were 
taken and put on ice. After washing with ice-cold glucose 5%, the samples 
were suspended in 5 ml of ice-cold TCA 5%, and put on ice overnight. The 
suspension was fractionated as described by de Mol et al. [19]. The amount of 
radioactivity in the RNA, DNA and protein fractions was determined by 
liquid scintillation counting. The protein content of each fraction was deter- 
mined by the method of Lowry-Hartree [20]. The phosphor content of each 
fraction was determined by the method of L indberg and Ernster  [21]. Correc- 
tions for small amounts of nucleic acid in the protein fraction and for small 
amou'fits of protein in the nucleic acid fractions were made when calculating 
the amount of radioactivity bound per mg RNA, DNA or protein. 
RESULTS AND DISCUSSION 
Binding of BABQ to calf thymus DNA and polynucleotides involves a pH 
dependent reaction: at low pH, alkylation is enhanced (Fig. 2). Electrochemi- 
cal reduction further  promotes binding: after electrochemical reduction, bind- 
ing is already observable at physiological pH (Fig. 2). It appears that 
alkylation of DNA and polynucleotides can be achieved by both reduced and 
unreduced BABQ at low pH, but that reduction greatly enhances the number 
of adducts. 
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Fig. 2. pH-dependence of binding of electrochemically reduced BABQ to calf thymus DNA and 
synthetic polynucleotides. BABQ was completely reduced at pH 7.0; samples contained 100 ~M 
reduced [14C]BABQ, 90 ~M Tris-acetate buffer and 1.76 mM DNA or polynucleotide, calculated as 
phosphate and were incubated for 90 rain at 37°C. D, caJi thymus DNA; A, poly(dGdC) 
poly(dGdC); O, poly(dAdT) • poly(dAdT); A, poly(dG) " poly(dC); e, poly(dA) • poly(dT); ~, 
binding of unreduced BABQ to calf thymus DNA. 
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These results are in agreement with earlier observations [8] where the 
UV absorbance maximum of alkylated DNA at 343 nm was used to measure 
the amount of alkylation. We have obtained similar results by studying DNA 
interstrand cross-linking by BABQ and BABQ derivatives [8]. The increased 
alkylation and cross-linking of DNA by BABQ at lower pH indicates that 
protonation of the aziridine ring is an essential step for alkylation; this is in 
agreement with a high reactivity of protonated aziridines towards nucleo- 
philic species [22]. The reaction mechanism, involving the presence of an azir- 
idinium ion intermediate, is analogous to that of nitrogen mustard 
compounds [23]. 
Reduction of BABQ activates the compound by making the quinone moiety 
electron rich; this facilitates protonation of the aziridine rings and subse- 
quent ring opening and alkylation. 
When the pH-binding profiles of polynucleotides are compared with those 
of DNA (Fig. 2), the same pH-dependence is observed. However, the extent 
of alkylation varies: binding to poly(dA • dT) is lower than binding to DNA, 
whereas binding to poly(dG • dC) equals or slightly exceeds binding to DNA 
(Fig. 2). Binding to poly{dG} • poly(dC) was lower than to the other polynu- 
cleotides, whereas binding to poly(dA} • poly{dT) reached its maximum value 
at a higher pH than the other polynucleotides or calf thymus DNA {Fig. 2). 
Nucleotide specificity of alkylating compounds containing an aziridine 
group or nitrogen mustard function has been studied by several authors. 
Mitomycin C binds via aziridine ring opening preferentially to the N2 posi- 
tion of guanine in calf thymus DNA and poly(dG • dC) after reductive activa- 
tion and to the N7 position of guanine after acid activation [24]. Nornitrogen 
mustard and aziridine ethanol bind preferentially to the N7 position of guan- 
osine and guanine in calf thymus DNA [25]. More specifically, nitrogen mus- 
tards bind preferentially to runs of contiguous guanines in pBR322 DNA [26]. 
These results can be explained by the presence of a negative molecular elec- 
trostatic potential near the reaction site [27], which facilitates attack by a 
positively charged species. Using molecular orbital calculations, the N7 posi- 
tion of guanine was found to be the preferred alkylation site for protonated 
aziridine, where the 06 atom of guanine is involved in base-pair hydrogen 
bonding [28]. In view of the similarity between the reactive intermediates of 
BABQ and nitrogen mustards, the same preference for alkylation on guanine 
could be expected in the case of BABQ. Our results on binding to polynucleo- 
tides do not unambiguously support preferential binding to guanine residues. 
The increased binding to poly(dG dC) compared to poly(dA dT) is in 
agreement with guanine preference, however the efficient binding to 
poly{dA) • poly{dT) is not. Possibly in this latter case steric factors could be 
important, e.g. poly(dA) • poly(dT) is a helix with a distinctively shorter 
pitch and a narrower minor groove than normal B-form DNA [29]. 
An attempt was made to identify the nature of the BABQ adduct{s) by 
enzymatic digestion of DNA to nucleosides after reaction with BABQ. Before 
digestion, unbound BABQ products were removed by Sephadex filtration 
and extractions. After digestion, modified nucleosides were separated by 
200 
HPLC, first using acetic acid (pH 3.3) as eluent and detection at 343 nm, 
which is the UV maximum of DNA-BABQ adduct before digestion. Digestion 
of unreacted calf thymus DNA yielded no products with UV absorbance at 
343 rim, therefore peaks with absorbance at 343 nm are ascribed to BABQ 
adducts. Two principal peaks eluted with absorbance at 343 nm (peak A at 
39% methanol and peak B at 53% methanol; Fig. 3). These two peaks were 
quantitatively obtained from repeated runs (yielding fractions A and B), and 
lyophilized and again analyzed by HPLC, this time using Tris buffer (pH 7.2) 
as eluent and detection at 343 and 275 nm. Fraction A appeared to consist of 
two components that had not been separated at pH 3.3: a compound with UV 
absorbance around 275 nm (peak C) and a product which showed absorbance 
' ' ' ' (~0 40 50 60 70 1 
% methanol 
Fig. 3. HPLC ehromatogram of digested BABQ-DNA adduct, obtained by electrochemical reduc- 
tion of a mixture containing 0.5 mg • m1-1 calf thymus DNA and 2 mM BABQ in 50 mM phos- 
phate buffer (pH 6.0) and digested with DNAse I, nuclease P1 and alkaline phosphatase, as
described in Materials and Methods. Gradient elution was from 100% acetic acid (15 mM; pH 3.3) 
to 100% methanol; detection was at 343 nm. 
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at 343 nm (peak D). The retention time and UV spectrum of the compound of 
peak D were identical to that of 2,5-bis(ethanolamino)-l,4-benzoquinone (Fig. 
4, broken line). Fraction B appeared to consist of a peak eluting at 470/0 
methanol (peak E), a peak (F) which had the same retention time as peak D 
(39% methanol) and a peak (G) at 330/0 methanol with absorbance at 275 nm. 
Incubation with acid did not result in further degradation of fraction B. The 
UV spectrum of peak E is given in Fig. 4 (solid line). In addition to the UV 
maximum at 343 nm, a maximum at 287 nm is observed at neutral pH and at 
274 nm at pH 3.3. The UV maxima indicate that the compound is a BABQ 
adduct, with extra UV maxima at wavelengths where nucleosides how 
absorbance. At alkaline pH, the UV maximum shifts towards 320 nm, indicat- 
ing substitution of (ring opened) aziridine groups by hydroxyl groups, as 
described by Kusai et al. [30]. During the isolation of peak E, a great loss in 
UV absorption at 343 nm occurred. Mass spectrometry confirmed the iden- 
tity of compound D (r,z/z = 192; bis(ethanolamino)-l,4-benzoquinone after loss 
of OH-groups), but could not reveal the identity of compound E due to its 
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Fig. 4. Broken line: UV spectrum of 2,5-bis(ethanolamino)-l,4-benzoquinone; solid line: UV spec- 
trum of peak E (see text). 
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instability. Peak G could be a (modified) DNA base, resulting from adduct 
decomposition. However, the absorption spectrum of compound G was not 
identical to that of one of the principle DNA bases, nor were its HPLC elu- 
tion properties. Unfortunately peak G was not obtained in sufficient purity 
to allow unambiquous interpretation of its mass spectrum. Nevertheless, 
these results indicate that there is one (unstable) main nucleoside adduct 
from BABQ alkylation. This nucleoside adduct probably contains BABQ with 
opened aziridine rings, in view of the similarity of its UV maximum with 
ring-opened BABQ (Fig. 4). 
The observed instability of the adduct is remarkable, as adducts from 
nitrogen mustard derivatives are readily obtained by enzymatic or acid 
hydrolysis [25,31]. 
To study whether BABQ semiquinone or BABQ hydroquinone is involved 
in the alkylation of DNA, the binding of BABQ to calf thymus DNA was fol- 
lowed at pH 5.0 under several reducing conditions. Electrochemical reduction 
of BABQ in aqueous medium produces the two-electron reduced species (hy- 
droquinone), whereas the one-electron reduced species (semiquinone) can only 
directly be produced electrochemically, by reduction in non-aqueous media 
[32,33]. However, the semiquinone is present in a dismutation-compropor- 
tionation equilibrium with hydroquinone and quinone (Eqn. 1), as demon- 
strated for e.g. diaziquone [34,35]: 
2Q- ~ Q + Q2- (1) 
Three time-dependent experiments were performed: (a) Incubation of BABQ 
with DNA under nitrogen, without electrochemical reduction (only oxidized 
BABQ present). (b) Incubation of BABQ with DNA under nitrogen, while 
BABQ is reduced during incubation with DNA, as indicated by the decreas- 
ing cathode current (Fig. 5). In this case DNA is exposed to BABQ semiqui- 
none formed in a dismutation equilibrium (Eqn. 1) and to BABQ 
hydroquinone. (c) Incubation under nitrogen, while DNA is added after 
reduction of BABQ and BABQ is kept reduced electrochemically (low cathode 
current, Fig. 5). In this experiment, DNA is exposed to only BABQ hydroqui- 
none. The results are represented in Fig. 5. When BABQ is incubated with 
DNA without electrochemical reduction (Expt. a), binding of BABQ to calf 
thymus DNA is low. Electrochemically reduced BABQ, incubated with DNA 
at pH 5.0 under nitrogen (Expt. c), binds to DNA somewhat more than non- 
reduced BABQ. At pH 5.0 BABQ hydroquinone is less stable than at pH 7.0, 
therefore reduction occurred at pH 7.0. At aeration after incubation at pH 
5.0 with DNA, an increase in binding is observed (results not shown). This 
indicates that part of the alkylating aziridinyl groups remained intact during 
incubation at pH 5.0 and that the low binding in Expt. c is not caused by loss 
of the aziridinyl group by ring opening. During electrochemical reduction of 
BABQ in the presence of DNA (Expt. b), binding to DNA takes place most 
efficiently. Under these conditions DNA is able to react with BABQ semiqui- 
none; we therefore conclude that BABQ semiquinone is the most reactive 
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Fig. 5. Time-dependence of binding of BABQ to calf thymus DNA at pH 5.0 under nitrogen. 
Samples contained 225 pM [I~C]BABQ, 0.6 rag/rot calf thymus DNA and 5 mM Tris-acetate buffer 
(pH 5.0). D, binding of unreduced BABQ (Expt. a); ix, binding during electrochemical reduction of 
BABQ (Expt. b); O, binding of electrochemically reduced BABQ (Expt. c); - - - ,  cathode current of 
Expt. b; - - ,  cathode current of Expt. c. At t = 105 rain, Expt. b was continued under air, 
without further reduction, after pH adjustment to 7.0. Samples were incubated at 25°C (A); 
37°C (o) and 45°C (I) .  
species in the alkylation reaction with DNA. Electrochemical reduction of 
BABQ as used to study DNA binding (e.g. see Fig. 2) yields two electron 
reduced BABQ (hydroquinone), from which in the presence of oxygen the 
alkylating semiquinone is formed by reoxidation and dismutation (Eqn. 1). 
Analogous to our results is the observation of Nguyen et al. [34], that a dia- 
ziquone radical generating mixture has a higher growth inhibiting activity 
on P388 cells than diaziquone. 
Alkylation by the semiquinone form of quinoid antitumour drugs like 
adriamycin [36], mitomycin C [37] or more simple quinones like menadione 
[38] has been described in the literature. With simple quinones, direct reac- 
tion of the quinone moiety is involved [39]. However, in the case of BABQ 
the aziridinyl group is the alkylating function: this is demonstrated by the 
necessity of two aziridine groups for the formation of DNA interstrand cros- 
slinks [8] and the pH dependence of DNA alkylation as described in this 
paper. 
The pK a value of the aziridine ring is expected to increase upon reduction, 
as reduction increases the electron density in the BABQ molecule. Two-elec- 
tron reduction will obviously increase the overall electron density to a larger 
extent han one-electron reduction. However, this does not lead to a higher 
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alkylating activity of two-electron reduced BABQ compared to BABQ semi- 
quinone. Possibly the pK a value of the aziridine ring does not simply corre- 
late with total molecular electron density. Conformational changes might be 
related with the reduction process, e.g. from ab initio calculations at the 
STO-3G level it appears that the position of the aziridine ring with respect 
to the benzoquinone ring changes upon reduction due to the formation of 
hydrogen bonds (E.E. Moret, to be published). 
The binding process in Expt. b was further followed, after stopping the 
reduction process and aeration, at different emperatures. During aeration, 
DNA alkylation continues and is dependent upon the temperature. At 25°C, 
binding continues for at least 180 min, but eventually decreases (Fig. 5). At 
37°C and 42°C, DNA alkylation continues during approx. 45 min and then 
declines (Fig. 5). The continuation of DNA alkylation after termination of 
electrochemical reduction and exposing the reaction mixture to air can be 
explained by the formation of semiquinone radicals during autoxidation of 
BABQ hydroquinone. This process continues as long as BABQ hydroquinone 
reoxidizes. However, the decrease of covalent binding indicates that the 
DNA adduct is not stable; decomposition of the adduct is faster at elevated 
temperatures. These results are in agreement with the difficulties encoun- 
tered with the isolation of nucleoside adducts as described above. 
In contrast with the observed pH dependence for BABQ binding to DNA 
and polynucleotides (Fig. 2), binding of BABQ to the protein BSA increases 
at higher pH values (Fig. 6). Binding to BSA is not increased by electrochem- 
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Fig. 6. pH-dependence of binding by BABQ to bovine serum albumin. Samples contained 100 ~M 
reduced or non reduced [14C]BABQ (BABQ was completely reduced at pH 7.0), 90 pM Tris-acetate 
buffer and 0.68 mg/ml albumin and were incubated for 90 rain at 37°C (O, BABQ; A, electro- 
chemically reduced BABQ). e,  pH-dependence of BABQ adduct formation with glutathione. 
These samples contained 100 pM [14C]BABQ, 100 pM glutathione and 100 mM Tris-acetate buffer 
and were incubated for 120 min at 37°C. HPLC fractions eluted with tris buffer were collected, 
made up to 10 ml volume, and measured for UV absorption at340 rim. 
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ical reduction of BABQ when the reaction pH is under 8.0 and even 
decreases at higher pH-values. Addition of glutathione and cysteine inhibits 
the binding of BABQ to BSA at pH 8.0 (Table I). Binding of BABQ to BSA 
evidently involves a reaction mechanism that is essentially different from 
that of binding to DNA. Attack by the (protonated) aziridinyl group can not 
be involved in binding to BSA, as neither protonation or reduction lead to 
increased binding. The partial inhibition by glutathione and cysteine of 
BABQ binding to BSA indicate that in the nucleophilic addition with BABQ, 
-SH groups might be involved. The observed increase in binding of BABQ 
to BSA around pH 7.0-7.5 may also reflect a change in the conformation of 
BSA as described for human serum albumin, the so-called neutral-to-base or
N-B transition between pH 6 and 9, which affects drug binding [40]. 
HPLC analysis of a mixture of 100 ~M BABQ, 100 ~M glutathione and 100 
~M Tris (pH 8.0), incubated at 37°C during 40 rain (Fig. 7), revealed that 
apart from glutathione, several products with absorbance at 340 nm eluted 
with 5 mM Tris buffer (pH 7.4}, which had UV maxima near 345 nm. These 
peaks are not BABQ or BABQ decomposition products resulting from acid or 
alkali hydrolysis, as these are eluted only with methanol-buffer mixtures. 
Peak A shows UV maxima at 340 and 252 nm; peak B shows UV maxima at 
350 and 258 nm. The UV maximum at higher wavelengths indicates the pres- 
ence of a BABQ product and is close to the UV maximum of aziridine ring 
opened BABQ bis(ethanolamino)benzoquinone, at 343 nm [30]. In view of 
these spectral properties and the retention times, these peaks are ascribed 
to glutathione-BABQ adducts. The total amount of glutathione adducts was 
assessed by measuring the UV absorbance at 340 nm of the Tris eluate, 
made up to a fixed volume. As in the case of BABQ binding to BSA, the 
amount of water-soluble BABQ adducts increases with increasing pH (Fig. 6). 
This increase in binding at higher pH-values is in accordance with deprotona- 
tion of the SH-group, which facilitates attack by a nucleophile [41]. The pH- 
value where UV absorbance at 340 nm is half-maximal, however, is 
substantially lower than the pK a value of 8.8 for glutathione [42]. Binding of 
SH-groups to benzoquinones and naphthoquinones by nucleophilic attack, 
TABLE I 
EFFECTS OF GLUTATHIONE AND CYSTEINE ON THE BINDING OF BABQ TO BSA 
Samples containing 100 ~M BABQ, 0.6 mg/ml BSA, 100 mM Tris-acetate buffer (pH 8.0) and 100 
~M glutathione or cysteine, as indicated, were incubated for 1 h at 37°C. 
Component added to the Binding of BABQ to BSA 
incubation mixture {mmol BABQ/mol albumin) 
Control 283 _+ 12 
100 ~M glutathione 134 -+ 6 
100 ~M cysteine 144 _+ 12 
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d ~ .9  D 
100 % buffer 1 O0 % methanol 
Fig. 7. HPLC chromatogram of a reaction mixture of 100 ~M BABQ, 100 ~M glutathione and 100 
mM Tris-acetate buffer pH 8.0, incubated at 37°C for 40 min. Eluent was 100% tris buffer (5 
mM; pH 7.4)/100% methanol. Detection was at 340 nm. 
leading to formation of a hydroquinone adduct, has been described e.g. by 
Rossi et al. [43] and Ross et al. [44]. 
The covalent binding of BABQ to proteins, DNA and RNA in intact cells 
was studied in E. coli bacteria. We used the same E. coli strains previously 
in a differential DNA repair test [12]: E. coli 343/753 is deficient in DNA 
repair and E. coli 343/765 has wild type DNA repair. In E. coli, BABQ is 
reductively activated by bacterial reductases. Table II shows the results of 
binding by BABQ to cellular fractions of both E. coli strains. Extensive pro- 
tein binding was observed in both strains. BABQ is readily taken up by E. 
coli, or associates rapidly to the cells, as an increase in total radioactivity in 
E. coli could only be observed during the first 10 min of incubation. The 
DNA repair deficient strain shows a slightly higher binding to all cellular 
fractions. The DNA-repair deficient strain is killed more easily [12] due to 
DNA alkylation and the absence of certain DNA repair enzymes. However, a 
higher amount of alkylated DNA was not demonstrated in this strain. 
In conclusion, one-electron reduction of BABQ to the semiquinone appears 
to be the activating step for DNA alkylation, while two-electron reduction 
leads to a relatively unreactive species, that can be conjugated cellularly and 
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TABLE II 
BINDING OF BABQ TO CELLULAR FRACTIONS OF E. COLI K12-343/753 (DNA REPAIR 
DEFICIENT) AND 343/765 (WILD TYPE DNA REPAIR) 
Cell suspensions containing 8 × 108 cells/ml were incubated at 37 °C in glucose-phosphate buffer 
(pH 7.0) in the presence of 10 ~M BABQ under shaking for 30 min. 
Cellular Binding to E. coli Binding to E. coli 
fraction K12-343/765 K12-343/753 
RNA 1.32 mmol/mol nucl. 1.78 mmol/mol nucl. 
DNA 1.22 mmoi/mol nucl. 1.99 mmol/mol nucl. 
Protein 40.0 mmol]mol 58.4 mmol/mol 
excreted. Binding of BABQ to albumin proceeds by a reaction mechanism 
that, in contrast to DNA alkylation, does not involve aziridine ring protona- 
tion and opening. In E. coli, appreciable protein binding next to DNA bind- 
ing is demonstrated. The difference in reaction chemistry between alkylation 
of DNA and of protein is interesting from the viewpoint of drug design: the 
specificity of BABQ for DNA alkylation relative to protein alkylation 
increases at lower pH values. This offers perspectives for the development 
of more specifically acting BABQ derivatives. When certain tumour cells are 
more acidic and hypoxic than normal cells, this type of drug might have 
more specific activity with respect to DNA alkylation in these cells. 
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